Pharmaxis Hails Positive Results in Phase 1 Scarring Trial
Release Date: 31/08/2021 2:00pm
Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news its novel topical drug treatment for scarring has delivered positive phase 1 clinical trial results and will now advance to the next stage of development in patients with established scars.
Watch the interview here.
Categories: Video Content